Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06596265 · ClinicalTrials.gov registry record

Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study

A clinical trial of Hypertension and Anxiety, sponsored by Duke University.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT06596265 is a study of Hypertension and Anxiety that is actively recruiting participants, run by Duke University. The registered enrollment target is 1,000 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06596265, a study of Hypertension and Anxiety, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

The Fit2Lead prospective cohort study examines the effects of a park-based youth mental health and resilience afterschool program on youth participant mental health, resilience, physical fitness, and violence prevention outcomes. Duke will perform a secondary analysis of the data collected as part of the Fit2Lead prospective cohort study run by Miami-Dade County Parks and Recreation.

Interventions

  • BEHAVIORAL Fit2Lead Group 1-2

Study Locations (1)

Florida

  • Miami-Dade County Parks, Recreation and Open Spaces Department - Miami

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2016-02-17
Est. Completion 2028-06-17

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT06596265

The ClinicalTrials.gov registry entry for NCT06596265 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Fit2Lead Group 1-2 is the first listed.

NCT06596265 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06596265 about?

NCT06596265 is a clinical study titled "Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study". The Fit2Lead prospective cohort study examines the effects of a park-based youth mental health and resilience afterschool program on youth participant mental health, resilience, physical fitness, and violence prevention outcomes. Duke will perform a secondary analysis of the data collected as part o...

What is the current status of trial NCT06596265?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2016-02-17. Estimated completion is 2028-06-17.

What conditions does trial NCT06596265 study?

This clinical trial studies the following conditions: Hypertension, Anxiety, Overweight or Obesity, Prehypertension, Wellness, Psychological.

What interventions are being tested in trial NCT06596265?

The interventions under investigation include: Fit2Lead Group 1-2 (BEHAVIORAL).

Who is sponsoring clinical trial NCT06596265?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06596265 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.